nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
|
Hohaus, S. |
|
1999 |
44 |
1 |
p. S13-S17 |
artikel |
2 |
Bcl-2 inhibits early apoptotic events and reveals post-mitotic multinucleation without affecting cell cycle arrest in human epithelial tumor cells exposed to etoposide
|
Elliott, Mary Jane |
|
1999 |
44 |
1 |
p. 1-11 |
artikel |
3 |
Cellular sensitization to cisplatin and carboplatin with decreased removal of platinum-DNA adduct by glucose-regulated stress
|
Yamada, Manabu |
|
1999 |
44 |
1 |
p. 59-64 |
artikel |
4 |
Comparative neurotoxicity of oxaliplatin, ormaplatin, and their biotransformation products utilizing a rat dorsal root ganglia in vitro explant culture model
|
Luo, Feng R. |
|
1999 |
44 |
1 |
p. 29-38 |
artikel |
5 |
Dose-intense salvage therapy after neoadjuvant chemotherapy: feasibility and preliminary results
|
Palangié, T. |
|
1999 |
44 |
1 |
p. S24-S25 |
artikel |
6 |
Erratum: Cancer Chemother Pharmacol (1999) 43: 106–114
|
, |
|
1999 |
44 |
1 |
p. 90 |
artikel |
7 |
FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the `out-patient' setting
|
Davidson, N. G. P. |
|
1999 |
44 |
1 |
p. S18-S23 |
artikel |
8 |
Ifosfamide and vinorelbine in metastatic breast cancer in patients with prior anthracycline therapy
|
Aziz, Z. |
|
1999 |
44 |
1 |
p. S9-S12 |
artikel |
9 |
Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer
|
Chang, A. Y. |
|
1999 |
44 |
1 |
p. S26-S28 |
artikel |
10 |
Ifosfamide given by continuous-intravenous infusion in association with vinorelbine in patients with anthracycline-resistant metastatic breast cancer: A phase I–II clinical trial
|
Campisi, C. |
|
1999 |
44 |
1 |
p. S1-S4 |
artikel |
11 |
In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer
|
Chien, Mark |
|
1999 |
44 |
1 |
p. 81-87 |
artikel |
12 |
Local disposition kinetics of floxuridine after intratumoral and subcutaneous injection as monitored by [19F]-nuclear magnetic resonance spectroscopy in vivo
|
Port, Ruediger |
|
1999 |
44 |
1 |
p. 65-73 |
artikel |
13 |
Metabolism of N -[2-(dimethylamino)ethyl]acridine-4-carboxamide in cancer patients undergoing a phase I clinical trial
|
Schofield, Philip C. |
|
1999 |
44 |
1 |
p. 51-58 |
artikel |
14 |
Miltefosine as a topical treatment for cutaneous metastases in breast carcinoma
|
Clive, S. |
|
1999 |
44 |
1 |
p. S29-S30 |
artikel |
15 |
Omeprazole does not alter plasma methotrexate clearance
|
Whelan, Jeremy |
|
1999 |
44 |
1 |
p. 88-89 |
artikel |
16 |
Pharmacokinetics and biotransformations of oxaliplatin in comparison with ormaplatin following a single bolus intravenous injection in rats
|
Luo, Feng R. |
|
1999 |
44 |
1 |
p. 19-28 |
artikel |
17 |
Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01
|
Kurata, Noriaki |
|
1999 |
44 |
1 |
p. 12-18 |
artikel |
18 |
Phase I and pharmacokinetic analysis of high-dose tamoxifen and chemotherapy in normal and tumor-bearing dogs
|
Waddle, J. R. |
|
1999 |
44 |
1 |
p. 74-80 |
artikel |
19 |
Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy
|
Lobo, F. |
|
1999 |
44 |
1 |
p. S5-S8 |
artikel |
20 |
Phase I study of the cytotoxic agent N -[2-(dimethylamino)ethyl]acridine-4-carboxamide
|
McCrystal, Michael R. |
|
1999 |
44 |
1 |
p. 39-44 |
artikel |
21 |
Plasma pharmacokinetics of N -[2-(dimethylamino)ethyl]acridine-4-carboxamide in a phase I trial
|
Kestell, Philip |
|
1999 |
44 |
1 |
p. 45-50 |
artikel |
22 |
Treatment of skin metastases of breast cancer
|
ten Bokkel Huinink, W. |
|
1999 |
44 |
1 |
p. S31-S33 |
artikel |